Skip to main content
. 2021 Dec 7;11(12):500. doi: 10.3390/bios11120500
AbC Capture antibody
Abs Second antibody
ADAM A disintegrin and metalloprotease
ALP Alkaline phosphatase
BTLA B- and T- lymphocyte attenuator
CEA Carcinoembryonic antigen
CLL Chronic lymphocytic leukemia
CRC Colorectal cancer
CT scan Computed tomography scan
CTC Circulating tumor cells
ctDNA Circulating tumor DNA
CTL Cytotoxic T lymphocytes
CTLA-4 Cytotoxic T-lymphocyte–associated antigen 4
DLBCL Diffuse large B-cell lymphoma
EC Electrochemical biosensors
EGFR Epidermal growth factor receptor
ELISA Enzyme-linked immunoassay
FRET Fluorescence resonance energy transfer
GSPE-MFD Gold screen-printed electrode-based microfluidic devices
HCC Hepatocellular carcinoma
HER2 Human epidermal growth factor receptor 2
Hq Hydroquinone
HRP Horse radish peroxide
IC Immune checkpoints
ICB Immue checkpoint blockade
IFN-γ Interferon gamma
IgG Immunoglobulin G
IHC Immunohistochemistry
IL-2 Interleukin-2
LAG-3 Lymphocyte activation gene 3
LOD Limit-of-detection
MAGE-A Melanoma-associated antigen-A
MICB Multiplexed immune checkpoint biosensor
MNP Magnetic nanoparticles
MUC1 Mucin 1
NPC Nasopharyngeal carcinoma
NTME Non-tumor microenvironment
PD-1 Programmed death 1
PD-L1 Programmed death-1 ligand
PSA Prostate specific antigen
PTC Papillary thyroid cancer
ScFv Single-chain variable fragment
sLAG-3 Serum lymphocyte activation gene-3
sPD-1 Serum programmed death-1
sPD-L1 Serum programmed death-1 ligand
SPR Surface plasmon resonance
sTIM-3 Serum T cell immunoglobulin and mucin-domain containing-3
TAA Tumor-associated antigen
TIM-3 T cell immunoglobulin and mucin-domain containing-3
TME Tumor microenvironment
TNF-α Tumor necrosis factor alpha
TSA Tumor-specific antigen